| Literature DB >> 31323776 |
Rokhsareh Akbarzadeh1, Anvar Asadi2, Peter Ozaveshe Oviroh1, Tien-Chien Jen3.
Abstract
A novel enhanced visible light absorption BiOCl/AgCl/pan> class="Chemical">BiVO4 heterojunction of photocatalysts could be obtained through a one-pot hydrothermal method used with two different pH solutions. There was a relationship between synthesis pH and the ratio of BiOCl to BiVO4 in XRD planes and their photocatalytic activity. The visible light photocatalytic performances of photocatalysts were evaluated via degradation of diclofenac (DCFF) as a pharmaceutical model pollutant. Furthermore, kinetic studies showed that DCF degradation followed pseudo-first-order kinetics. The photocatalytic degradation rates of BiOCl/AgCl/BiVO4 synthesized at pH = 1.2 and pH = 4 for DCF were 72% and 47%, respectively, showing the higher activity of the photocatalyst which was synthesized at a lower pH value. It was concluded that the excellent photocatalytic activity of BiOCl/AgCl/BiVO4 is due to the enhanced visible light absorption formation of a heterostructure, which increased the lifetime of photo-produced electron-hole pairs by creating a heterojunction. The influence of pH during synthesis on photocatalytic activity in order to create different phases was investigated. This work suggests that the BiOCl/AgCl/BiVO4 p-n heterojunction is more active when the ratio of BiOCl to BiVO4 is smaller, and this could be achieved simply by the pH adjustment. This is a promising method of modifying the photocatalyst for the purpose of pollutant degradation under visible light illumination.Entities:
Keywords: BiOCl/AgCl/BiVO4; degradation; diclofenac; heterojunction; photocatalyst
Year: 2019 PMID: 31323776 PMCID: PMC6679066 DOI: 10.3390/ma12142297
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1XRD patterns of BAB1 and BAB2 photocatalyst.
Pattern list of XRD patterns of BAB1 and BAB2 photocatalyst.
| Compound | BAB1 | BAB2 | ||
|---|---|---|---|---|
| Reference Code | Score | Reference Code | Score | |
| BiOCl | 04-007-4915 | 62 | 04-007-4915 | 75 |
| BiVO4 | 04-016-0302 | 50 | 00-014-0688 | 48 |
| AgCl | 01-071-5209 | 31 | 04-007-3906 | 33 |
Figure 2SEM image of BAB1 (a), BAB2 (b), TEM image of BAB1 (c), BAB2 (d) and SAED pattern of a BAB 1 (e) and BAB2 (f).
Figure 3(a) Ultraviolet–visible diffuse reflectance spectra (UV-Vis DRS) and (b) determination of indirect interband transition energies for BAB1 and BAB2.
Figure 4FT-IR spectra of BiOCl/AgCl/BiVO4 synthesized at pH = 1.2 (BAB1) and BiOCl/AgCl/BiVO4 synthesized at pH = 4 (BAB2).
Figure 5(a) N2-sorption isotherms and (b) corresponding pore-size distribution (inset) curves for BiOCl/AgCl/BiVO4 synthesized at pH = 1.2 (BAB1) and BiOCl/AgCl/BiVO4 synthesized at pH = 4 (BAB2).
BET surface areas, pore volume, and pore size in the samples.
| Sample | SBET (m2/g) a | Pore Volume (cm3/g) b | Average Pore Size (nm) c |
|---|---|---|---|
| BAB1 | 6.16 | 0.044 | 25.9 |
| BAB2 | 5.09 | 0.033 | 23.8 |
a BET surface area calculated from the linear part of the BET plot. b Barrett-Joyner-Halenda (BJH) adsorption cumulative volume of pores between 17.0 Å and 3000.0 Å diameter. c Adsorption average pore diameter (4V/A by BET).
Figure 6Raman spectra of the BiOCl/AgCl/BiVO4 synthesized at pH = 1.2 (BAB1) and BiOCl/AgCl/BiVO4 synthesized at pH = 4 (BAB2).
Figure 7Photocatalytic degradation of degradation of diclofenac (DCF) (a); the corresponding pseudo-first-order reaction kinetics (b); and corresponding photocatalytic degradation efficiencies in solutions with a different pH (c) for BAB1 and BAB2 photocatalysts.